DRAP’s drug pricing mechanism under legal scrutiny as IHC seeks record
ISLAMABAD - The Drug Regulatory Authority of Pakistan’s (DRAP) mechanism for imposing and enforcing maximum retail prices (MRP) on pharmaceutical products has come under judicial scrutiny after a pharmaceutical company challenged the legality of the regulatory approach before the Islamabad High Court.
No comments yet. Be the first to add a perspective.